doi:10.3969/j.issn.1673-8640.2017.12.010

Abstract

CLC Number:

R446.1

Figures/Tables 4

References 9

[1]	Blood urea nitrogen(BUN)[EB/OL] . (2017-02-24)[2017-02-25]. .
[2]	中华人民共和国卫生和计划生育委员会. WS/T404.5—2015 临床常用生化检验项目参考区间第5部分:血尿素,肌酐[S]. 北京:中国标准出版社,2015.
[3]	顾科萍,王亚平,余伟,等. 应用ROC曲线分析冠心病患者中游离脂肪酸的临床应用价值[J]. 检验医学,2017,32(5):367-369.
[4]	易观智库. 互联网+体检:大数据推动体检行业升级[EB/OL]. (2015-07-06)[2017-02-25]. .
[5]	LUKE R G.Uremia and the BUN[J]. N Engl J Med,1981,305(20):1213-1215.
[6]	DUNSTAN E J.Urea/creatinine ratios,age,and gastrointestinal bleeding[J]. Lancet,1986,1(8493):1327.
[7]	BRISCO M A,COCA S G,CHEN J,et al.Blood urea nitrogen/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure[J]. Circ Heart Fail,2013,6(2):233-239.
[8]	SHIBA N.Blood urea nitrogen/creatinine ratio in acute heart failure patients[J]. Circ J,2015,79(7):1446-1447.
[9]	ZHANG G M,GUO X X,ZHANG G M.Limiting the testing of urea:urea along with every plasma creatinine test?[J]. J Clin Lab Anal,2017,31(5).

性别	SCr（mg/dL）	eGFR[mL/（min·1.73 m²）]
女性	≤0.7	151×（0.993）^年龄×（SCr/0.7）^-0.328
女性	>0.7	151×（0.993）^年龄×（SCr/0.7）^-1.210
男性	≤0.9	149×（0.993）^年龄×（SCr/0.7）^-0.415
男性	>0.9	149×（0.993）^年龄×（SCr/0.7）^-1.210

性别	SCr（mg/dL）	eGFR[mL/（min·1.73 m²）]
女性	≤0.7	151×（0.993）^年龄×（SCr/0.7）^-0.328
女性	>0.7	151×（0.993）^年龄×（SCr/0.7）^-1.210
男性	≤0.9	149×（0.993）^年龄×（SCr/0.7）^-0.415
男性	>0.9	149×（0.993）^年龄×（SCr/0.7）^-1.210

组别	例数	年龄（岁）	Cr（μmol/L）	尿素（mmol/L）
男性	17 440	41（30~50）	72（64~78）	5.2（4.3~5.9）
女性	10 809	36（30~43）	54（47~59）^*	4.4（3.6~5.1）^*
合计	28 249	39（30~48）	65（54~74）	4.9（4.0~5.7）

组别	例数	年龄（岁）	Cr（μmol/L）	尿素（mmol/L）
男性	17 440	41（30~50）	72（64~78）	5.2（4.3~5.9）
女性	10 809	36（30~43）	54（47~59）^*	4.4（3.6~5.1）^*
合计	28 249	39（30~48）	65（54~74）	4.9（4.0~5.7）

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 9

Related Articles 15

Recommended Articles

Metrics